Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 12/20 | 0.36 |
| ▸ | CA2 | P00918 | 12/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 3/20 | 0.32 |
| ▸ | MMP2 | P08253 | 3/20 | 0.32 |
| ▸ | MMP9 | P14780 | 3/20 | 0.32 |
| ▸ | MMP8 | P22894 | 3/20 | 0.32 |
| ▸ | MMP13 | P45452 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL98592 | 0.88 | HSD11B1 (0.33) | — | |
| SCHEMBL3779517 | 0.86 | CA1 (0.34) | CA1CA2 | |
| SCHEMBL3144008 | 0.83 | PTGS1 (0.32) | CA1CA2 | |
| SCHEMBL548130 | 0.82 | PIK3CD (0.42) | CA1CA2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL5857793 | 0.82 | CA2 (0.36) | CA1CA2 | |
| SCHEMBL3132254 | 0.82 | PTGS1 (0.32) | CA1CA2 | |
| SCHEMBL3139331 | 0.82 | PTGS1 (0.32) | CA1CA2 | |
| SCHEMBL1802710 | 0.81 | CA2 (0.43) | CA1CA2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL5858639 | 0.81 | CA2 (0.38) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL5856167 | 0.78 | CA1 (0.35) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7396960-B2 | Sulfonium salts | TOYO GOSEI CO., LTD. (JP) | 2008-07-08 | — | — | US | disclosed |
| US-20070219368-A1 | Sulfonium salts | TOYO GOSEI CO., LTD. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-7192685-B2 | Positive resist composition and method of forming resist pattern using the same. | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-20040197708-A1 | Positive resist composition and method of forming resist pattern using the same | FUJI PHOTO FILM CO., LTD. | 2004-10-07 | — | — | US | disclosed |
| EP-1462858-A1 | Positive resist composition and method of forming resist pattern using the same | Fuji Photo Film Co., Ltd. (JP) | 2004-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219368-A1 | Sulfonium salts | C1S, F12, C1R | CA1 421/4885CA2 198/4885PIK3CD 4525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.